KLK3 and cardiovascular disorder: We could not check additional levels in 1 patient who refused additional testing after PSA reached 0.27 ng/mL at the 14.6 month follow-up, and another patient expired from cardiovascular disease after reaching a 0.21 ng/mL PSA level.